Evidence map›Paper›PMID 29499275›Full record

ArticleNeuropharmacology2018

Altered hippocampal synaptic function in transgenic mice with increased astrocyte expression of CCL2 after withdrawal from chronic alcohol.

Jennifer G Bray, Kenneth C Reyes, Amanda J Roberts, Donna L Gruol

Abstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neuroimmune signaling in alcohol use disorder.Pharmacology, biochemistry, and behavior · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jennifer G BrayMolecular and Cellular Neuroscience Department, The Scripps Research Institute, La Jolla, CA 92037, USA.
Kenneth C ReyesMolecular and Cellular Neuroscience Department, The Scripps Research Institute, La Jolla, CA 92037, USA.
Amanda J RobertsMolecular and Cellular Neuroscience Department, The Scripps Research Institute, La Jolla, CA 92037, USA.
Donna L GruolMolecular and Cellular Neuroscience Department, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: gruol@scripps.edu.
Scripps Research Institute · US

Funding

IL-6 involvement in alcohol-withdrawal excitabilityR01AA024484 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI GRUOL, DONNA L · 2016 to 2020
$2.1M
Mouse Target Assessment CoreU01AA020893 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTS, AMANDA J · 2011 to 2015
$1.5M
Alcohol-Chemokine Interactions and NeurotransmissionRC1AA019261 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI GRUOL, DONNA L · 2009 to 2010
$833k
Alcohol and Chemokine InteractionsF32AA020441 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI BRAY, JENNIFER GRACE · 2011 to 2011
$45k
NIAAA NIH HHS F32 AA020441NIAAA NIH HHS R01 AA024484NIAAA NIH HHS RC1 AA019261NIAAA NIH HHS U01 AA020893
6 · The paper itself

Abstract

CNS actions of the chemokine CCL2 are thought to play a role in a variety of conditions that can have detrimental consequences to CNS function, including alcohol use disorders. We used transgenic mice that express elevated levels of CCL2 in the CNS (CCL2-tg) and their non-transgenic (non-tg) littermate control mice to investigate long-term consequences of CCL2/alcohol/withdrawal interactions on hippocampal synaptic function, including excitatory synaptic transmission, somatic excitability, and synaptic plasticity. Two alcohol exposure paradigms were tested, a two-bottle choice alcohol (ethanol) drinking protocol (2BC drinking) and a chronic intermittent alcohol (ethanol) (CIE/2BC) protocol. Electrophysiological measurements of hippocampal function were made ex vivo, starting ∼0.6 months after termination of alcohol exposure. Both alcohol exposure/withdrawal paradigms resulted in CCL2-dependent interactions that altered the effects of alcohol on synaptic function. The synaptic alterations differed for the two alcohol exposure paradigms. The 2BC drinking/withdrawal treatment had no apparent long-term consequences on synaptic responses and long-term potentiation (LTP) in hippocampal slices from non-tg mice, whereas synaptic transmission was reduced but LTP was enhanced in hippocampal slices from CCL2-tg mice. In contrast, the CIE/2BC/withdrawal treatment enhanced synaptic transmission but reduced LTP in the non-tg hippocampus, whereas there were no apparent long-term consequences to synaptic transmission and LTP in hippocampus from CCL2-tg mice, although somatic excitability was enhanced. These results support the idea that alcohol-induced CCL2 production can modulate the effects of alcohol exposure/withdrawal on synaptic function and indicate that CCL2/alcohol interactions can vary depending on the alcohol exposure/withdrawal protocol used.

Indexed as

AlcoholismAnimalsChemokine CCL2HippocampusLong-Term PotentiationMiceMice, TransgenicNeuronal PlasticitySubstance Withdrawal SyndromeSynaptic TransmissionTime FactorsChemokine CCL2Chronic intermittent alcohol exposureHippocampusMemory and learningSynaptic plasticitySynaptic transmissionTwo-bottle choice alcohol drinking

Identifiers

PMID29499275
PMCPMC5975123
OpenAlexW2790092392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.